311 A pharmacogenomic scoring system predicting median time-to-progression on sunitinib as first line treatment in patients with metastatic renal cell carcinoma

2012 ◽  
Vol 11 (1) ◽  
pp. e311-e311a
Author(s):  
B. Beuselinck ◽  
A. Karadimou ◽  
B. Claes ◽  
D. Lambrechts ◽  
J. Berkers ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Median Time ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Scoring System ◽  
Line Treatment ◽  
Time To Progression ◽  
First Line ◽  
First Line Treatment

Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell Carcinoma

2012 ◽  
Vol 31 (1) ◽  
pp. 15-24 ◽  
Author(s):  
Mary Kilonzo ◽  
Jenni Hislop ◽  
Andrew Elders ◽  
Cynthia Fraser ◽  
Donald Bissett ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects

2019 ◽  
Vol 39 (10) ◽  
pp. 5559-5564 ◽  
Author(s):  
RIIKKA-LIISA VUORINEN ◽  
NIINA PAUNU ◽  
TAINA TURPEENNIEMI-HUJANEN ◽  
TAINA REUNAMO ◽  
ANTTI JEKUNEN ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis

2020 ◽  
Vol 18 (4) ◽  
pp. 244-251.e4 ◽  
Author(s):  
Fernando Sabino M. Monteiro ◽  
Andrey Soares ◽  
Márcio Debiasi ◽  
Fabio A. Schutz ◽  
Fernando Cotait Maluf ◽  
...  
Keyword(s):  
Systematic Review ◽  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Meta Analysis ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document